Virpax Pharmaceuticals In... (VRPX)

0.27

0.02 (9.76%)

At close: Apr 28, 2025, 12:59 PM

0.27

0.00%

After-hours: Apr 28, 2025, 12:59 PM EDT

Virpax Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	1.51M	17.23K	1.87M	1.87M	9.14M	12.15M	14.8M	16.99M	19M	20.56M	26.06M	30.8M	36.84M	41.71M	10.47M	12.26M	54.8K	256.5K	416.91K	-41.54K	41.54K	-48.37K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	83.07K	n/a	96.74K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	392.34K	176.39K	73K	-41.54K	n/a	-48.37K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.39K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.33K	n/a
Other Current Assets	37.91K	273K	128.12K	505.9K	283.37K	448.43K	424.83K	543.69K	496.27K	2.59M	2.55M	2.88M	2.57M	1.1M	5.73K	3.05K	535.00	3.64K	382.5K	n/a	467.00	n/a
Total Current Assets	1.56M	304.16K	2.59M	3.13M	9.63M	13.04M	15.95M	18.49M	19.67M	23.64M	29.4M	34.75M	39.57M	43.27M	11.39M	13.22M	73.07K	274.56K	825.15K	41.54K	46.72K	48.37K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	392.34K	176.39K	73K	-41.54K	n/a	-48.37K
Total Assets	1.56M	304.16K	2.59M	3.13M	9.63M	13.04M	15.95M	18.49M	19.67M	23.64M	29.4M	34.75M	39.57M	43.27M	11.39M	13.22M	465.41K	450.95K	898.15K	n/a	46.72K	n/a
Account Payables	n/a	n/a	75.4K	13.28K	18.46K	33.19K	76.06K	45.25K	37.64K	14.32K	n/a	10.4K	19.84K	572.00	10K	4.66K	22.11K	6.77K	17.82K	n/a	3.5K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-64.2K	-163.78K	-22.11K	-6.77K	n/a	n/a	-3.5K	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.51K	50.51K	543.99K	535.54K	1.46M	n/a	1.26M	n/a
Other Current Liabilities	n/a	2.26M	2.5M	2.5M	6M	5M	2M	2M	2M	n/a	8K	n/a	n/a	10K	1.7M	1.31M	1.03M	11.37K	n/a	n/a	819.61K	n/a
Total Current Liabilities	2.47M	2.36M	5.39M	4.34M	7.69M	6.53M	3.65M	3.29M	3.09M	4.21M	2.48M	2.19M	2.09M	1.81M	2.83M	2.64M	3.66M	3.27M	3.54M	n/a	2.78M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.02M	1.02M	1.02M	1.03M	42.7K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.09M	4.21M	2.48M	n/a	n/a	n/a	1.02M	1.02M	1.02M	1.03M	42.7K	n/a	1.26M	n/a
Total Liabilities	2.47M	2.36M	5.39M	4.34M	7.69M	6.53M	3.65M	3.29M	3.09M	4.21M	2.48M	2.19M	2.09M	1.81M	3.85M	3.66M	4.68M	4.3M	3.58M	n/a	2.78M	n/a
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.07M	1.07M	1.57M	1.57M	1.51M	n/a	1.26M	n/a
Common Stock	149.00	49.00	28.00	12.00	12.00	117.00	117.00	117.00	117.00	117.00	117.00	117.00	117.00	117.00	50.00	49.00	31.00	31.00	155.00	n/a	30.00	n/a
Retained Earnings	-71.61M	-68.22M	-66.21M	-62.76M	-59.54M	-54.98M	-48.99M	-45.88M	-44.35M	-41.37M	-33.73M	-27.84M	-22.7M	-18.59M	-15.37M	-13.03M	-10.65M	-9.94M	-8.23M	n/a	-6.31M	n/a
Comprehensive Income	n/a	n/a	n/a	-0.00	-0.00	n/a	n/a	n/a	-0.00	n/a	0.00	-0.00	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	-2.73M	-0.00	-1.19M
Shareholders Equity	-913.76K	-2.05M	-2.79M	-1.21M	1.93M	6.51M	12.3M	15.2M	16.58M	19.43M	26.92M	32.56M	37.48M	41.46M	7.54M	9.56M	-4.22M	-3.85M	-2.68M	-2.73M	-2.73M	-1.19M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	83.07K	n/a	96.74K